Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Walter Jeske, Mary Lewis, Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, Jawed Fareed, PhD, Sid Mehrota

Blood (2017) 130 (Supplement 1): 4905.

https://doi.org/10.1182/blood.V130.Suppl_1.4905.4905

Published: 2017

Journal Articles

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, MD, Walter Jeske, PhD, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, PhD, Jawed Fareed, PhD, Mary Lewis

Blood (2016) 128 (22): 2608.

https://doi.org/10.1182/blood.V128.22.2608.2608

Published: 2016

Journal Articles

Case Report of a Primary Splenic Marginal Zone Lymphoma Patient Presenting with Factor VII Inhibitor

Caroline Hamm, MD, FRCPC, Anargyros Xenocostas, MD, FRCPC, Sindu M. Kanjeekal, MD, FRCPC, Alejandro Lazo-Langner, MD, MSC

Blood (2010) 116 (21): 4927.

https://doi.org/10.1182/blood.V116.21.4927.4927

Published: 2010

Journal Articles

A Case of FVII Inhibitor.

Michael Joshua Levitt, MD, Arthur A. Topilow, MD, William Lerner, MD, Peter Mencel, MD, Carl Henningson, MD, David Benjamin Greenberg, MD, Claire S. Philipp, MD

Blood (2010) 116 (21): 3655.

https://doi.org/10.1182/blood.V116.21.3655.3655

Published: 2010

Journal Articles

Antisense Oligonucletide Mediated Depletion of Factor VII Provides Protection from Ferric Chloride Induced Thrombosis without Increased Bleeding Risk in Mice

Jeff Crosby, PhD, Chenguang Zhao, Dacao Gao, Andy Siwkowski, Hong Zhang, MD, Brett P. Monia, PhD

Blood (2008) 112 (11): 3080.

https://doi.org/10.1182/blood.V112.11.3080.3080

Published: 2008

Journal Articles

Membrane-Bound and Soluble Tissue Factor - Fuse and Fire Extinguisher.

Saulius Butenas, PhD, Thomas Orfeo, PhD, Kathleen E. Brummel-Ziedins, PhD, Kenneth G. Mann, PhD

Blood (2004) 104 (11): 123.

https://doi.org/10.1182/blood.V104.11.123.123

Published: 2004

NARROW

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Case Report of a Primary Splenic Marginal Zone Lymphoma Patient Presenting with Factor VII Inhibitor

A Case of FVII Inhibitor.

Antisense Oligonucletide Mediated Depletion of Factor VII Provides Protection from Ferric Chloride Induced Thrombosis without Increased Bleeding Risk in Mice

Membrane-Bound and Soluble Tissue Factor - Fuse and Fire Extinguisher.

Email alerts

ASH Publications

American Society of Hematology

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Case Report of a Primary Splenic Marginal Zone Lymphoma Patient Presenting with Factor VII Inhibitor

A Case of FVII Inhibitor.

Antisense Oligonucletide Mediated Depletion of Factor VII Provides Protection from Ferric Chloride Induced Thrombosis without Increased Bleeding Risk in Mice

Membrane-Bound and Soluble Tissue Factor - Fuse and Fire Extinguisher.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only